Definitive Contract 75F40126C00062

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Versar, Inc., a global project management company, for "Consultation and Peer Review: Risk Assessment for Contaminants in Food (Maternal and Infant Health)." The BPA call, which is not set aside, has a potential value of $243,704.08 and a completion date of November 9, 2023. Versar, Inc. will provide professional services and peer review support...

This federal contract award is for a Blanket Purchase Agreement (BPA) call with Versar, Inc., a global project management company, to provide consulting and peer review services related to food contaminants for the U.S. Food and Drug Administration (FDA). The contract has a ceiling value of $1,315,464.07 and a completion date of October 30, 2025. The contract is a firm fixed-price type awarded under the Multiple Award Schedule (MAS) program. The contract does not have a set-aside designation....

The United States Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $428,021.98 delivery order contract to Versar Inc. under the Multiple Award Schedule (MAS) master contract vehicle. The contract provides Peer Review and Scientific Assessment Support services to HHS FDA from the prime contractor's place of performance in Silver Spring, Maryland. The period of performance spans from September 26, 2022 through March 31, 2024 and utilizes labor hour pricing.

The Food and Drug Administration awarded a $25,140 delivery order to Versar, Inc. on May 7, 2008, for an external peer review of a risk profile. This firm fixed-price delivery order, which was completed by September 23, 2008, was issued without a set-aside designation, allowing Versar to compete directly against other qualified vendors. The work was performed at Versar's facility in North Springfield, Virginia. Versar, a Washington D.C.-based global project management and professional services...

The Department of Health and Human Services Food and Drug Administration awarded Versar, Inc. a firm fixed price Blanket Purchase Agreement (BPA) call contract with a potential value of $109,521.00. The contract is for "Consultation and External Peer Review for Risk and Safety Assessments" under the existing BPA #HHSF223201700015B, which is part of the General Services Administration's Professional Services Schedule. Versar is a global project management firm that specializes in...

<p>The Food and Drug Administration awarded a $2,982,375 definitive contract to Verantos Inc. for valid evidence and reliable real-world data to increase fidelity and yield clarity in regulatory decision-making (VERIFY) on September 20, 2024.</p> <p>The contract is firm fixed price with no set-aside. Place of performance is Silver Spring, MD 20903. The contract ceiling is $2,982,375 with an ultimate completion date of September 29, 2027.</p>

The Food and Drug Administration awarded a delivery order valued at $229,478 to Vets Synergetic Group LLC for a Project Coordinator V position, with performance completion targeted for January 30, 2027. This award was issued without a set-aside designation and represents labor-hour pricing under a delivery order contract type. The work will be performed at the FDA's Silver Spring, Maryland facility. Vets Synergetic Group LLC is a minority-owned, small disadvantaged business structured as an...

<p>The Food and Drug Administration issued a delivery order to The Mitre Corporation on June 22, 2026, with a ceiling value of $144,999.00 under a cost-plus-fixed-fee pricing model.</p> <p>The order supports the Reviewer Recognition and Excellence Program (RREP). Place of performance is West McLean, VA. Ultimate completion is scheduled for August 3, 2026. No set-aside was used for this delivery order.</p>

This is a federal contract award to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, by the Food and Drug Administration (FDA), a civilian agency. The contract is for an &quot;INDUSTRY PROFILE OF FOOD SAMPLING FACILITIES&quot; under the FDA's &quot;ECONOMIC STUDIES OF FDA REGULATIONS&quot; program. The contract has a ceiling value of $78,594.00 and was awarded on September 12, 2018, with a completion date of January 11, 2020. This award is a Delivery Order under the...

<p>The Food and Drug Administration issued a purchase order to the National Academy of Sciences on September 18, 2024, valued at $100,000.00, for FDA support to the NASEM Leadership Consortium. The order is firm fixed price with no set-aside designation. Performance takes place in Washington, DC 20418. Ultimate completion is scheduled for September 29, 2025.</p>